Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group

被引：0
|
作者：
Fountzilas, E. [1 ]
Lalla, T. [1 ]
Karakatsoulis, G. [1 ]
Papazisis, K. [1 ]
Exarchos, K. [1 ]
Koumarianou, A. [1 ]
Nikolaidi, A. [1 ]
Binas, I. [1 ]
Mauri, D. [1 ]
Karageorgopoulou, S. [1 ]
Razis, E. [1 ]
Christopoulou, A. [1 ]
Boutis, A. [1 ]
Douganiotis, G. [1 ]
Zagouri, F. [1 ]
Stamatopoulou, S. [1 ]
Spathas, N. [1 ]
Tryfonopoulos, D. [1 ]
Psyrri, A. [1 ]
Koutras, A. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp HeCOG, Data Off, Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113954
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3LBA
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [32] Efficacy and safety of lapatinib in Chinese breast cancer patients: a real-world study
    Ye, Xuan
    Luo, Xin
    Du, Qiong
    Li, Huan
    Liu, Hong-Yue
    Yu, Bo
    Zhai, Qing
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [33] Real-world experience with trastuzumab deruxtecan in patients with breast cancer: 6 month-interim analysis of an all-patient postmarketing surveillance in Japan
    Tsurutani, Junji
    Mizutani, Hideki
    Tanabe, Ayumi
    CANCER RESEARCH, 2024, 84 (09)
  • [34] Real World Data for Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases
    Toler, Andrew
    Bobolts, Laura R.
    Mangurian, Mark
    Pozotrigo, Melissa
    Wise, Corey
    Solomon, Hiywete
    Hartung, Nicole
    Makielski, Rory
    Marur, Shika
    Ravindranathan, Meera
    Marur, Shanthi
    CANCER RESEARCH, 2023, 83 (05)
  • [35] Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
    Fountzilas, Elena
    Koliou, Georgia-Angeliki
    Vozikis, Athanassios
    Rapti, Vassiliki
    Nikolakopoulos, Achilleas
    Boutis, Anastasios
    Christopoulou, Athina
    Kontogiorgos, Ioannis
    Karageorgopoulou, Sofia
    Lalla, Efthalia
    Tryfonopoulos, Dimitrios
    Boukovinas, Ioannis
    Rapti, Cleopatra
    Nikolaidi, Adamantia
    Karteri, Sofia
    Moirogiorgou, Evangelia
    Binas, Ioannis
    Mauri, Davide
    Aravantinos, Gerasimos
    Zagouri, Flora
    Saridaki, Zacharenia
    Psyrri, Amanda
    Bafaloukos, Dimitrios
    Koumarianou, Anna
    Res, Eleni
    Linardou, Helena
    Mountzios, Giannis
    Razis, Evangelia
    Fountzilas, George
    Koumakis, Georgios
    ESMO OPEN, 2020, 5 (04)
  • [36] Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer
    Mazzotta, Marco
    Krasniqi, Eriseld
    Barchiesi, Giacomo
    Pizzuti, Laura
    Tomao, Federica
    Barba, Maddalena
    Vici, Patrizia
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (02)
  • [37] Initial real-world experience with ribociclib in advanced breast cancer
    Nawaz, Azhar
    Zekri, Jamal
    Rasool, Haleem
    Ibrahim, Refaei
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [38] The efficacy and safety of alpelisib in breast cancer: A real-world analysis
    Miller, Jenn
    Armgardt, Emily
    Svoboda, Alison
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1152 - 1156
  • [39] Advanced stage clear-cell epithelial ovarian cancer: The Hellenic Cooperative Oncology Group experience
    Pectasides, Dimitrios
    Fountzilas, George
    Aravantinos, Gerassimos
    Kalofonos, Charalambos
    Efstathiou, Helen
    Farmakis, Dimitrios
    Skarlos, Dimosthenes
    Pavlidis, Nikolaos
    Economopoulos, Theofanis
    Dimopoulos, Meletios A.
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 285 - 291
  • [40] Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)
    Kawakami, Hisato
    Nakanishi, Koki
    Makiyama, Akitaka
    Konishi, Hirotaka
    Morita, Satoshi
    Narita, Yukiya
    Sugimoto, Naotoshi
    Minashi, Keiko
    Imano, Motohiro
    Inamoto, Rin
    Kodera, Yasuhiro
    Kume, Hiroki
    Yamaguchi, Keita
    Hashimoto, Wataru
    Muro, Kei
    GASTRIC CANCER, 2025, 28 (01) : 51 - 61
12345